HomeCompareASROF vs JNJ

ASROF vs JNJ: Dividend Comparison 2026

ASROF yields 210.11% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASROF wins by $159.23M in total portfolio value
10 years
ASROF
ASROF
● Live price
210.11%
Share price
$0.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$159.25M
Annual income
$82,243,792.82
Full ASROF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ASROF vs JNJ

📍 ASROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASROFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASROF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASROF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASROF
Annual income on $10K today (after 15% tax)
$17,859.02/yr
After 10yr DRIP, annual income (after tax)
$69,907,223.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ASROF beats the other by $69,906,520.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASROF + JNJ for your $10,000?

ASROF: 50%JNJ: 50%
100% JNJ50/50100% ASROF
Portfolio after 10yr
$79.63M
Annual income
$41,122,310.30/yr
Blended yield
51.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASROF
No analyst data
Altman Z
-8.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASROF buys
0
JNJ buys
0
No recent congressional trades found for ASROF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASROFJNJ
Forward yield210.11%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$159.25M$20.0K
Annual income after 10y$82,243,792.82$827.78
Total dividends collected$150.47M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASROF vs JNJ ($10,000, DRIP)

YearASROF PortfolioASROF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$31,711$21,010.61$10,676$355.77+$21.0KASROF
2$96,198$62,267.22$11,407$389.39+$84.8KASROF
3$279,468$176,536.80$12,198$426.53+$267.3KASROF
4$778,345$479,313.58$13,056$467.62+$765.3KASROF
5$2,080,429$1,247,600.24$13,987$513.12+$2.07MASROF
6$5,342,599$3,116,539.69$14,998$563.56+$5.33MASROF
7$13,196,356$7,479,775.31$16,098$619.52+$13.18MASROF
8$31,386,678$17,266,576.75$17,295$681.69+$31.37MASROF
9$71,964,525$38,380,779.65$18,599$750.82+$71.95MASROF
10$159,245,834$82,243,792.82$20,022$827.78+$159.23MASROF

ASROF vs JNJ: Complete Analysis 2026

ASROFStock

Astrocast SA, an Internet of Things (IoT) focused nanosatellite company, provides satellite IoT connectivity services to track, monitor, manage, and communicate with assets in remote regions worldwide. Its products portfolio includes the Astronode S, a bidirectional satellite communication module for connecting IoT devices to the Astrocast nanosatellite network; Astronode S+, a ready-to-install satellite communication device; Astronode DevKit, which has the Astronode S architecture that enables to connect your assets to the Astrocast nanosatellite network; and Patch Antenna, a miniaturized antenna designed for communication with Astrocast's constellation of IoT satellites in LEO. The company also offers Astrocast Portal that allows customers to manage their Astronode S modules and devices through a web application; and Astrocast API, which allows customers to manage their Astronode S modules and devices, retrieve messages received from their assets, and send commands back through a secure REST API built on standard JSON messages. It serves various industries, such as agriculture and livestock; environment and utilities; maritime; land transport; mining; and oil and gas. Astrocast SA was incorporated in 2014 and is based in Chavannes-Renens, Switzerland.

Full ASROF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ASROF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASROF vs SCHDASROF vs JEPIASROF vs OASROF vs KOASROF vs MAINASROF vs ABBVASROF vs MRKASROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.